OptimizeRx Corp·4

Nov 3, 4:45 PM ET

Paramore Miriam J 4

4 · OptimizeRx Corp · Filed Nov 3, 2021

Insider Transaction Report

Form 4
Period: 2021-11-02
Transactions
  • Sale

    Common Stock Pursuant to 10B5-1 Plan

    2021-11-02$95.45/sh15,000$1,431,75074,607 total
  • Exercise/Conversion

    Stock Option

    2021-11-0215,00094,318 total
    Exercise: $7.51From: 2020-12-31Exp: 2025-03-11Common Stock (15,000 underlying)
  • Exercise/Conversion

    Common Stock

    2021-11-02$7.51/sh+15,000$112,65089,607 total
Footnotes (1)
  • [F1]These shares sold pursuant to a plan of disposition adopted on March 24, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Documents

1 file
  • 4
    ownership.xmlPrimary